Search clinical trials for: Human immunoglobulin

Total 4745 results

Oxford University Clinical Research Unit, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Completed

Intrathecal Tetanus Immunoglobulin to Treat Tetanus (ITITTT)

Tetanus

Vietnam
Thomas Jefferson University

Terminated

Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study

Dermatomyositis

United States
University of Alberta
CSL Behring

Completed

A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) (SCIG-MG)

Myasthenia Gravis

Canada
Biotest
Syneos Health

Completed

This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Bulgaria, Czechia, Germany, Hungary, Serbia, Spain
Laboratoire français de Fractionnement et de Biotechnologies
TFS Trial Form Support

Completed

LIME Study (LFB IVIg MMN Efficacy Study) (LIME)

Motor Neuron Disease

Spain, United Kingdom, Italy, France
Therapure Biopharma Inc

Unknown

Study of PlasmaCap IG in Adults and Children With PIDD

Primary Immune Deficiency Diseases (PIDD)

United States, Canada
CSL Behring

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) (RECLAIIM)

Dermatomyositis

United States, Argentina, Belgium, France, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Spain, Switzerland, Ukraine
Assistance Publique - Hôpitaux de Paris
CSL Behring; Association ASLUMARE

Completed

Effect of Privigen Against Graft Loss (InAuGuRAL)

Kidney Transplantation

France
Wei Wang

Unknown

Intravenous Immunoglobulin for Acute Intracranial Hemorrhage

Intracranial Hemorrhage, Hypertensive

China
Pfizer

Active, not recruiting

ATGAM General Investigation

Aplastic Anemia

Japan
CSL Behring

Completed

Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10

Immune Thrombocytopenic Purpura

Poland, Ukraine, Germany, Russian Federation, Italy, United Kingdom
Bio Products Laboratory

Completed

A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy Volunteers

Healthy

United Kingdom
Bio Products Laboratory

Completed

A Study Comparing the Pharmacokinetics and Tolerance of D-Gam® to Rhophylac® in Rh-D-negative Healthy Volunteers.

Healthy

United Kingdom
Johannes Jakobsen
Baxter Healthcare Corporation

Completed

Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)

Multifocal Motor Neuropathy

Denmark
Bio Products Laboratory

Completed

A Study of the Safety and Efficacy of Vigam® Liquid in Patients With Primary or Secondary Antibody Deficiency

Primary or Secondary Antibody Deficiency

United Kingdom
PediaMed Pharmaceuticals

Unknown

Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism

Gastrointestinal Diseases | Signs and Symptoms, Digestive | Autistic Disorder | Child Development Disorders, Pervasive | Autism

United States
CSL Behring

Completed

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Primary Immune Deficiency

United States
Rigshospitalet, Denmark
The Ministry of Science, Technology and Innovation, Denmark

Completed

Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage

Secondary Recurrent Miscarriage

Denmark
CSL Behring

Completed

A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)

Multifocal Motor Neuropathy (MMN)

Switzerland, Italy, United Kingdom
Zhuhai Trinomab Pharmaceutical Co., Ltd.

Completed

Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus

Tetanus

China
Baxalta now part of Shire

Completed

Immune Globulin Subcutaenous (Human), 20%

Primary Immunodeficiency Diseases (PID)

Germany, Austria, Hungary, Sweden, United Kingdom
Assistance Publique - Hôpitaux de Paris

Terminated

Intravenous Immunoglobulin After Relapse in Vasculitis

ANCA + Vasculitides Relapsing Either Under Corticosteroid | and Immunosuppressant Therapies or After One Year | Post Treatment.

France
Hospices Civils de Lyon

Completed

Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study (IVIG)

Toxic Shock Syndrome

France
Bio Products Laboratory

Completed

A Multi-centre Open Study to Assess the Safety and Efficacy of Subgam®

Primary Antibody Deficiency

United Kingdom
Peking Union Medical College Hospital
Tongji Hospital

Unknown

The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia

2019-nCoV
Centre Hospitalier St Anne
Laboratoire français de Fractionnement et de Biotechnologies; Groupe Hospitalier...

Completed

Polyvalent Immunoglobulin in COVID-19 Related ARds (ICAR)

COVID-19 | Acute Respiratory Distress Syndrome

France
Octapharma
Premier Research Group plc

Completed

A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

Primary Immunodeficiency Diseases

United States
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D) (Meld-ATG)

Diabetes Mellitus, Type 1

Belgium, Austria, Slovenia, Denmark, United Kingdom, Italy, Finland, Germany
CSL Behring

Completed

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy

Common Variable Immunodeficiency | X-linked Agammaglobulinemia | Autosomal Recessive Agammaglobulinemia

Germany, United Kingdom, France, Italy, Poland, Romania, Spain, Sweden, Switzerland
Green Cross Corporation

Completed

An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia

Immune Thrombocytopenia

Korea, Republic of
CSL Behring

Completed

Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy

Chronic Inflammatory Demyelinating Polyneuropathy

Poland, France, Germany, Belgium, Finland
The University of Queensland

Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients (BEAT-BK)

Kidney Transplant Infection | Kidney Transplant Failure and Rejection | BK Viremia

Australia
Biotest
AMS Advanced Medical Services GmbH

Completed

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant (ZEUS)

Hepatitis B

Spain, United Kingdom, France, Italy
Cairo University

Completed

Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients

Burn Shock

Egypt
Centenario Hospital Miguel Hidalgo

Completed

Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia

COVID-19 Pneumonia

Mexico
Octapharma

Completed

Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Immune Thrombocytopenic Purpura

Austria
Hannover Medical School
Biotest

Recruiting

Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins (HBIG)

Chronic Hepatitis B

Germany
GWT-TUD GmbH

Completed

Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO) (FIGARO)

Primary Immunodeficiency | Secondary Immune Deficiency

Germany, Italy, France
Microgen

Recruiting

Clinical Study in the Treatment of Patients With Moderate Course of COVID-19

COVID-19

Russian Federation
National Cancer Institute (NCI)

Terminated

Tocilizumab for Patients With Cancer and COVID-19 Disease

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Pneumonia | Symptomatic COVID-19 Infection Laboratory-Confirmed | Severe Acute Respiratory Distress Syndrome | Pneumonitis

United States
Prothya Biosolutions

Completed

Pharmacokinetics of New HepBQuin

Healthy

Germany
Queen Saovabha Memorial Institute

Completed

Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response

Rabies

Thailand
Baxalta now part of Shire

Completed

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Primary Immunodeficiency Diseases (PID)

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants

Healthy Volunteers

United States
Peking University People's Hospital

Not yet recruiting

IVIg Plus Low Dose rhTPO for ITP in Pregnancy

Pregnancy Related | Immune Thrombocytopenia
Biopharma Plasma LLC
Lviv National Medical University; Vinnitsa National Medical University

Completed

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment

Pneumonia | Covid19

Ukraine
CSL Behring

Withdrawn

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Diffuse Cutaneous Systemic Sclerosis

Belgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

Study to Evaluate GR1801's Efficacy and Safety

Rabies Post-exposure Prophylaxis

China
Sinopharm Wuhan Plasma-derived Biotherapies Co....
China National Biotec Group Company Limited; Beijing Tiantan Biological Products...

Not yet recruiting

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

COVID-19

United Arab Emirates
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease

Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Japan

Search clinical trials for: Human immunoglobulin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations